EP3936130
Skömmtunaráætlun á valbensín til meðhöndlunar á ofhreyfniröskunum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
6.5.2015EP published:
14.2.2024EP application number:
21178882.3
EP translation filed:
29.4.2024Grant published:
15.6.2024EPO information:
European Patent Register
Max expiry date:
5.5.2035Expiry date:
5.5.2026Next due date:
31.5.2026
Title in English:
VALBENAZINE DOSAGE REGIMEN FOR THE TREATMENT OF HYPERKINETIC MOVEMENT DISORDERSLanguage of the patent:
English
Timeline
Today
6.5.2015EP application
14.2.2024EP Publication
29.4.2024Translation submitted
15.6.2024Registration published
5.5.2026Expires
Owner
Name:
Neurocrine Biosciences, Inc.Address:
6027 Edgewood Bend Court,, San Diego, California 92130, US
Inventor
Name:
O'BRIEN, ChristopherAddress:
San Diego, 92130, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201461989240 PDate:
6.5.2014Country:
US
Classification
Categories:
A61K 31/473, A61P 25/00, A61P 25/14, A61P 43/00
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 18.4.2024
Expires: 5.5.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 6.5.2025
Expires: 5.5.2026
Payer: Árnason Faktor ehf.